Thermo Fisher gets EU approval for $3.5B Phadia acquisition

08/29/2011 | MassDevice.com (Boston)

Thermo Fisher Scientific's purchase of Phadia, a maker of blood tests in Sweden, for $3.5 billion has received the green light from the European Commission. The transaction, which offers Thermo Fisher a broader footprint in specialty diagnostics, "would not raise competition concerns," the Commission said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY